Sun Pharmaceutical Industries Inc. has recalled 747 bottles of Riomet ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL, because a finished drug product tested positive for the NDMA impurity. This prescription medication is used to treat type 2 diabetes, and the recall affects 16-ounce bottles from a specific lot distributed across the country. Consumers should contact their healthcare provider or pharmacist immediately to discuss alternative treatments while they return the affected product.
The drug product contains N-nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen. While NDMA is a common environmental contaminant found in water and foods, exposure to higher-than-acceptable levels over long periods of time may increase the risk of cancer.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.